|
| 37093349 | Efficacy of salvage therapies after failure of adjuvant anti-PD-1 monotherapy for melanoma in the Chinese population: a multi-institutional cohort study. | Invest New Drugs | 2023 |
| 37388227 | The value of machine learning based radiomics model in preoperative detection of perineural invasion in gastric cancer: a two-center study. | Front Oncol | 2023 |
| 35047396 | Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas. | Front Oncol | 2022 |
| 36419879 | Clinicopathologic features, prognostic factors, and outcomes of visceral sarcomas: A retrospective 12-year single-center study. | Front Oncol | 2022 |
| 35875111 | Pan-Soft Tissue Sarcoma Analysis of the Incidence, Survival, and Metastasis: A Population-Based Study Focusing on Distant Metastasis and Lymph Node Metastasis. | Front Oncol | 2022 |
| 36313634 | A novel inflammatory signature for evaluating immune microenvironment status in soft tissue sarcoma. | Front Oncol | 2022 |
| 36303190 | Retraction Note: Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor. | J Hematol Oncol | 2022 |
| 36350007 | Therapeutic perspectives for adult soft tissue sarcoma-updates from the 2022 ASCO annual meeting. | Cancer Biol Med | 2022 |
| 34979500 | m<sup>6</sup>A regulator-mediated methylation modification patterns and tumor immune microenvironment in sarcoma. | Aging (Albany NY) | 2022 |
| 35279638 | An electrochemical biosensor for the assessment of tumor immunotherapy based on the detection of immune checkpoint protein programmed death ligand-1. | Biosens Bioelectron | 2022 |
| 34164199 | Construction, validation and, visualization of a web-based nomogram for predicting the overall survival and cancer-specific survival of leiomyosarcoma patients with lung metastasis. | J Thorac Dis | 2021 |
| 33718222 | Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors. | Front Oncol | 2021 |
| 34589515 | Postoperative Adjuvant Radiotherapy Can Delay the Recurrence of Desmoid Tumors After R0 Resection in Certain Subgroups. | Front Surg | 2021 |
| 34817950 | The efficacies and biomarker investigations of antiprogrammed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma. | Cancer Biol Med | 2021 |
| 34570440 | PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas. | Cancer Biol Med | 2021 |
| 33968790 | Corrigendum: Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors. | Front Oncol | 2021 |
| 32227592 | Clinicopathological features of pseudomyogenic hemangioendothelioma and precision therapy based on whole exome sequencing. | Cancer Commun (Lond) | 2020 |
| 31786466 | Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese cohort data from NCT03121846. | Biomed Pharmacother | 2020 |
| 33025763 | The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective study. | Cancer Commun (Lond) | 2020 |
| 32742476 | The new horizon of liquid biopsy in sarcoma: the potential utility of circulating tumor nucleic acids. | J Cancer | 2020 |
| 32587785 | Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy. | Cancer Biol Med | 2020 |
| 32120023 | IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. | Cancer Lett | 2020 |
| 32476297 | BRAF mutation and its inhibitors in sarcoma treatment. | Cancer Med | 2020 |
| 32322636 | Data analysis of PD-1 antibody in the treatment of melanoma patients. | Data Brief | 2020 |
| 30816108 | Phase II trial of VEGFR2 inhibitor apatinib for metastatic sarcoma: focus on efficacy and safety. | Exp Mol Med | 2019 |
| 31092619 | Editor's Note: Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment. | Clin Cancer Res | 2019 |
| 30886189 | Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China. | Sci Rep | 2019 |
| 29849960 | Apatinib as targeted therapy for sarcoma. | Oncotarget | 2018 |
| 30176876 | Histone deacetylase 6 in cancer. | J Hematol Oncol | 2018 |
| 27888623 | Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV. | Oncotarget | 2017 |
| 28447036 | Recent translational research into targeted therapy for liposarcoma. | Stem Cell Investig | 2017 |
| 28969086 | Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China. | Oncotarget | 2017 |
| 29020982 | The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors. | Chin J Cancer | 2017 |
| 26846098 | Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China. | Tumour Biol | 2016 |
| 28105146 | The role of T-box genes in the tumorigenesis and progression of cancer. | Oncol Lett | 2016 |
| 26546437 | Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma. | Tumour Biol | 2016 |
| 27458533 | Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients. | Cancer Biol Med | 2016 |
| 26993773 | Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor. | Oncotarget | 2016 |
| 26738504 | Roles of low-density lipoprotein receptor-related protein 1 in tumors. | Chin J Cancer | 2016 |
| 25578781 | Advances in targeted therapy for unresectable melanoma: new drugs and combinations. | Cancer Lett | 2015 |
| 25993412 | PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis. | PLoS One | 2015 |
| 23749326 | Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor. | Clin Transl Oncol | 2014 |
| 27358864 | The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute. | Stem Cell Investig | 2014 |
| 25418192 | Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma. | Chin J Cancer | 2014 |
| 25300797 | Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma. | J Hematol Oncol | 2014 |
| 24979249 | Advances in targeted therapy for osteosarcoma. | Discov Med | 2014 |
| 25189718 | Novel anti-melanoma treatment: focus on immunotherapy. | Chin J Cancer | 2014 |
| 24942472 | The genetic basis for inactivation of Wnt pathway in human osteosarcoma. | BMC Cancer | 2014 |
| 24291235 | Mesenchymal to epithelial transition in sarcomas. | Eur J Cancer | 2014 |
| 23292832 | Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas. | Med Oncol | 2013 |